The Role of the RNA-Binding Protein Family MEX-3 in Tumorigenesis.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
23 Jul 2020
Historique:
received: 02 07 2020
revised: 16 07 2020
accepted: 21 07 2020
entrez: 29 7 2020
pubmed: 29 7 2020
medline: 17 2 2021
Statut: epublish

Résumé

The muscle excess 3 (MEX-3) protein was first identified in

Identifiants

pubmed: 32717840
pii: ijms21155209
doi: 10.3390/ijms21155209
pmc: PMC7432607
pii:
doi:

Substances chimiques

Caenorhabditis elegans Proteins 0
MEX-3 protein, C elegans 0
Neoplasm Proteins 0
RNA-Binding Proteins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : German-Israeli Foundation for Scientific Research and Development
ID : I-37-414.11-2016
Organisme : Deutsche Forschungsgemeinschaft
ID : SE 581/22-1
Organisme : Dr. Werner Jackstädt-Stiftung
ID : -

Références

Biosci Rep. 2019 Jun 25;39(6):
pubmed: 31171715
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2999-3004
pubmed: 14973191
Science. 2017 May 26;356(6340):
pubmed: 28495876
Clin Cancer Res. 2018 Jul 15;24(14):3366-3376
pubmed: 29496759
Mol Med Rep. 2012 Sep;6(3):575-80
pubmed: 22692246
Oncol Lett. 2017 Oct;14(4):4415-4427
pubmed: 29085437
Clin Cancer Res. 2018 Jul 15;24(14):3239-3241
pubmed: 29674509
Mol Cancer. 2014 May 23;13:120
pubmed: 24885513
Nat Rev Mol Cell Biol. 2018 May;19(5):327-341
pubmed: 29339797
J Mol Cell Biol. 2015 Oct;7(5):388-401
pubmed: 25948865
Hepatology. 2016 Oct;64(4):1033-48
pubmed: 27338022
Mol Cell. 2016 Aug 18;63(4):696-710
pubmed: 27453046
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5646-51
pubmed: 24706898
Br J Exp Pathol. 1948 Feb;29(1):58-69
pubmed: 18865105
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Oncoimmunology. 2015 Mar 2;4(6):e1008805
pubmed: 26155421
Cell. 1996 Oct 18;87(2):205-16
pubmed: 8861905
PeerJ. 2020 Jan 21;8:e8252
pubmed: 31998552
Sci Rep. 2018 Oct 15;8(1):15264
pubmed: 30323214
Mol Immunol. 2013 Sep;55(2):135-8
pubmed: 23140835
Cancer Immunol Immunother. 2019 Oct;68(10):1689-1700
pubmed: 31375885
J Pathol. 2008 Dec;216(4):387-93
pubmed: 18853439
Hypertension. 2006 Nov;48(5):883-91
pubmed: 17015768
BMC Cancer. 2018 May 3;18(1):517
pubmed: 29720118
Oncogene. 2018 Sep;37(38):5233-5247
pubmed: 29849121
Sci Rep. 2017 Oct 24;7(1):13905
pubmed: 29066822
EMBO J. 2012 Aug 29;31(17):3596-606
pubmed: 22863774
Nucleic Acids Res. 2013 Apr;41(7):3986-99
pubmed: 23408853
Nucleic Acids Res. 2007;35(4):1289-300
pubmed: 17267406
Development. 2014 May;141(10):2096-107
pubmed: 24803656
FEBS J. 2020 Jan;287(1):53-72
pubmed: 31306552
Semin Cancer Biol. 2012 Aug;22(4):350-8
pubmed: 22465194
Biochem Biophys Res Commun. 2019 Nov 5;519(2):220-226
pubmed: 31493864
J Biol Chem. 2008 Nov 14;283(46):32131-42
pubmed: 18779327
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Oct;112(4):446-52
pubmed: 21862359
J Biol Chem. 2017 Sep 29;292(39):16221-16234
pubmed: 28808060
Oncotarget. 2017 Jun 7;8(33):54764-54774
pubmed: 28903380
Front Immunol. 2018 Jan 05;8:1942
pubmed: 29354136
Cell Res. 2016 Mar;26(3):288-303
pubmed: 26823206
Trends Mol Med. 2018 May;24(5):490-506
pubmed: 29627433
J Immunol. 1995 Apr 1;154(7):3283-99
pubmed: 7897212
Int J Clin Exp Pathol. 2014 Oct 15;7(11):7653-62
pubmed: 25550801
Front Immunol. 2012 Sep 21;3:296
pubmed: 23049533
FEBS J. 2008 Jun;275(11):2712-26
pubmed: 18422648
Cancer Immunol Immunother. 2020 Feb;69(2):315-324
pubmed: 31915854
Curr Opin Struct Biol. 2008 Jun;18(3):290-8
pubmed: 18515081
Nature. 1998 Feb 19;391(6669):806-11
pubmed: 9486653
Cell Rep. 2016 Aug 30;16(9):2456-71
pubmed: 27545879
Nat Commun. 2015 Oct 16;6:8670
pubmed: 26471122
Cell Rep. 2014 Sep 11;8(5):1347-53
pubmed: 25176652
Dev Biol. 2009 Feb 15;326(2):295-304
pubmed: 19100255
Protein Sci. 2018 Sep;27(9):1661-1669
pubmed: 30095198
Nat Rev Mol Cell Biol. 2011 Jul 22;12(8):505-16
pubmed: 21779027
Oncotarget. 2017 May 22;8(37):61215-61225
pubmed: 28977858
Mol Biol Cell. 2012 Apr;23(8):1404-13
pubmed: 22357625
Cancers (Basel). 2020 Jan 30;12(2):
pubmed: 32019099
PLoS One. 2017 Oct 5;12(10):e0185992
pubmed: 28982131
J Endocrinol. 2014 Jun;221(3):457-68
pubmed: 24741071
Gastric Cancer. 2018 Sep;21(5):756-764
pubmed: 29417297
Nature. 2013 Feb 28;494(7438):492-496
pubmed: 23446422
Onco Targets Ther. 2019 May 01;12:3285-3294
pubmed: 31118679
Trends Cancer. 2017 Jul;3(7):506-528
pubmed: 28718405
Front Immunol. 2020 May 15;11:940
pubmed: 32499786

Auteurs

Simon Jasinski-Bergner (S)

Institute for Medical Immunology, Martin Luther University Halle-Wittenberg, 06112 Halle (Saale), Germany.

André Steven (A)

Institute for Medical Immunology, Martin Luther University Halle-Wittenberg, 06112 Halle (Saale), Germany.

Barbara Seliger (B)

Institute for Medical Immunology, Martin Luther University Halle-Wittenberg, 06112 Halle (Saale), Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH